Genetic Changes In River Blindness Leading To Resistance To Drug Treatment
Ivermectin, the standard drug for treating river blindness (onchocerciasis), is causing genetic changes in the parasite that causes the disease, according to a new study by Roger Prichard (McGill University, Canada) and colleagues, published in the open-access journal PLoS Neglected Tropical Diseases. These genetic changes have previously been linked with parasites becoming resistant to ivermectin.
